Yu-Xiao Yang

12PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 01, 2024
Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab.

Timothy J Brown, Phyllis A Gimotty, Ronac Mamtani

|Mar 22, 2024
Exogenous Insulin Therapy Is Associated with the Risk of Advanced Colorectal Adenoma in Patients with Diabetes Mellitus.

Robert Lam, Wei-Ting Hwang, Sumanth Chennareddy

|Mar 14, 2024
Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study.

Nabeel Khan, Ramaswamy Sundararajan, Manthankumar Patel

|Aug 23, 2023
Do Polygenic Risk Scores Add to Clinical Data in Predicting Pancreatic Cancer? A Scoping Review.

Louise Wang, Alyssa A Grimshaw, Catherine Mezzacappa

|Mar 02, 2023
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis.

Timothy J Brown, Ronac Mamtani, Phyllis A Gimotty

|Feb 10, 2023
Dopamine agonists and risk of lung cancer in patients with restless legs syndrome.

Pilar Hernandez-Con, Justine Shults, Allison W Willis

Pageof 2

Frequent Collaborators

3 joint publications

Nabel Khan

2 joint publications

Louise Wang

2 joint publications

Timothy J Brown

2 joint publications

Ronac Mamtani